These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12435697)

  • 1. Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production.
    Martínez-Martínez L; Pascual A; Conejo Mdel C; García I; Joyanes P; Doménech-Sánchez A; Benedí VJ
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3926-32. PubMed ID: 12435697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.
    Sekowska A; Janicka G; Kłyszejko C; Wojda M; Wróblewski M; Szymankiewicz M
    Med Sci Monit; 2002 Mar; 8(3):BR100-4. PubMed ID: 11889457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey.
    Hasdemir UO; Chevalier J; Nordmann P; Pagès JM
    J Clin Microbiol; 2004 Jun; 42(6):2701-6. PubMed ID: 15184455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae.
    Chevalier J; Pagès JM; Eyraud A; Malléa M
    Biochem Biophys Res Commun; 2000 Aug; 274(2):496-9. PubMed ID: 10913366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany.
    Gröbner S; Linke D; Schütz W; Fladerer C; Madlung J; Autenrieth IB; Witte W; Pfeifer Y
    J Med Microbiol; 2009 Jul; 58(Pt 7):912-922. PubMed ID: 19502377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
    Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D
    Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended-spectrum β-lactamase.
    Tóth A; Kocsis B; Damjanova I; Kristóf K; Jánvári L; Pászti J; Csercsik R; Topf J; Szabó D; Hamar P; Nagy K; Füzi M
    Eur J Clin Microbiol Infect Dis; 2014 May; 33(5):837-43. PubMed ID: 24306097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.
    Ardanuy C; Liñares J; Domínguez MA; Hernández-Allés S; Benedí VJ; Martínez-Martínez L
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1636-40. PubMed ID: 9660996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae.
    Chen FJ; Lauderdale TL; Ho M; Lo HJ
    Microb Drug Resist; 2003; 9(3):265-71. PubMed ID: 12959405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Japanese tertiary hospital: silent shifting to CTX-M-15-producing K. pneumoniae.
    Higashino M; Murata M; Morinaga Y; Akamatsu N; Matsuda J; Takeda K; Kaku N; Kosai K; Uno N; Hasegawa H; Yanagihara K
    J Med Microbiol; 2017 Oct; 66(10):1476-1482. PubMed ID: 28893357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the role of porin mutations in susceptibility of beta lactamase producing Klebsiella pneumoniae isolates to ceftaroline and ceftaroline-avibactam.
    Khalid A; Lubián AF; Ma L; Lin RCY; Iredell JR
    Int J Infect Dis; 2020 Apr; 93():252-257. PubMed ID: 32061861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of association of OmpK35 and OmpK36 alteration and bla
    Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
    Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains.
    Martínez-Martínez L; García I; Ballesta S; Benedí VJ; Hernández-Allés S; Pascual A
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1850-2. PubMed ID: 9661034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Tran QT; Dupont M; Lavigne JP; Chevalier J; Pagès JM; Sotto A; Davin-Regli A
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1652-6. PubMed ID: 19164140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative activity of ertapenem against extended-spectrum beta-lactamase-producing or plasmid-mediated AmpC beta-lactamase-producing Klebsiella pneumoniae].
    Hernández JR; Conejo Mdel C; Pascual A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):27-30. PubMed ID: 19631421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.
    Martínez-Martínez L; Pascual A; Hernández-Allés S; Alvarez-Díaz D; Suárez AI; Tran J; Benedí VJ; Jacoby GA
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1669-73. PubMed ID: 10390220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.
    Tängdén T; Adler M; Cars O; Sandegren L; Löwdin E
    J Antimicrob Chemother; 2013 Jun; 68(6):1319-26. PubMed ID: 23478794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
    Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.